Pms77 - Decline in Healthcare Resource Consumption for Patients With Rheumatoid Arthritis Starting Certolizumab Pegol Therapy in France (The Eclair Study)

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.1791

Related search